Cargando…
Patients’ and professionals’ perspective of non-in-person visits in hereditary cancer: predictors and impact of the COVID-19 pandemic
PURPOSE: To identify predictors of patient acceptance of non-in-person cancer genetic visits before and after the COVID-19 pandemic and assess the preferences of health-care professionals. METHODS: Prospective multicenter cohort study (N = 578, 1 February 2018–20 April 2019) and recontacted during t...
Autores principales: | López-Fernández, Adrià, Villacampa, Guillermo, Grau, Elia, Salinas, Mónica, Darder, Esther, Carrasco, Estela, Torres-Esquius, Sara, Iglesias, Silvia, Solanes, Ares, Gadea, Neus, Velasco, Angela, Urgell, Gisela, Torres, Maite, Tuset, Noemí, Brunet, Joan, Corbella, Sergi, Balmaña, Judith |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
, The Author(s), under exclusive licence to the American College of Medical Genetics and Genomics
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023774/ https://www.ncbi.nlm.nih.gov/pubmed/33824504 http://dx.doi.org/10.1038/s41436-021-01157-2 |
Ejemplares similares
-
BARD1 Pathogenic Variants Are Associated with Triple-Negative Breast Cancer in a Spanish Hereditary Breast and Ovarian Cancer Cohort
por: Rofes, Paula, et al.
Publicado: (2021) -
Comprehensive Constitutional Genetic and Epigenetic Characterization of Lynch-Like Individuals
por: Dámaso, Estela, et al.
Publicado: (2020) -
SEOM clinical guidelines in Hereditary Breast and ovarian cancer
por: Llort, G., et al.
Publicado: (2015) -
Genetic and functional homologous repair deficiency as biomarkers for platinum sensitivity in TNBC: A case report
por: Gomez-Puerto, Diego, et al.
Publicado: (2022) -
Genetic Testing in Hereditary Breast and Ovarian Cancer Using Massive Parallel Sequencing
por: Ruiz, Anna, et al.
Publicado: (2014)